A new study has identified a molecular pathway that leads to abnormal cardiovascular blood clotting and turned it off using a popular class of cholesterol-lowering drugs, statins.
A new study has identified a molecular pathway that leads to abnormal cardiovascular blood clotting and turned it off using a popular class of cholesterol-lowering drugs, statins.